Objective To explore the altered expression of estrogen receptor (ER), progesterone
receptor (PR), human epidermal growth factor receptor 2 (HER2), and cell proliferation index …

Objective: To investigate the expression discordances of estrogen receptor (ER),
progesterone receptor (PR), human epidermal growth factor receptor2 (HER-2) and Ki-67 in …

Objective To explore the relationship between receptor heterogeneity and
clinicopathological characteristics in 166 patients with invasive breast cancer during …

The success of current hormonal therapies used in breast cancer patients often depends on
estrogen receptor (ER) status. The simultaneous pathological assessment of primary breast …

Objective: This study aims to investigate the correlation and clinical significance of hormone
receptors and the expressions of HER-2 and Ki-67 in breast cancer primary lesions and …

Only few studies reported in literature that has elucidated in detail the implications of
molecular typing in metastatic and recurrent breast cancer. In this prospective study, we …

Background In breast cancer, ER/PgR, HER2, and Ki-67 are important biological markers for
predicting prognosis and making effective treatment decisions. In addition, changes in …

Purpose In metastatic breast cancer, differences in expression patterns of estrogen receptor
(ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) …

Purpose Several studies have shown that estrogen receptor (ER) and progesterone receptor
(PR) expression and human epidermal growth factor receptor 2 (HER2) expression may …

Introduction: Carcinoma of the breast is the most common malignancy of women in Karachi.
The currentstudy was conducted with the objective of assessing estrogen receptor (ER) …